LII:NYSELennox International, Inc. Analysis
Data as of 2026-04-15 - not real-time
$520.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Lennox International (LII) is trading at $520.42, just below its 52‑week high of $689 and near the computed resistance level of $524.4, while the 20‑day SMA ($473) and 50‑day SMA ($510) sit comfortably below the price, indicating short‑term strength. However, the 200‑day SMA ($531) remains above the market price and the quantitative trend is flagged as bearish, supported by decreasing volume and a high 30‑day volatility of ~46%. The RSI of 62 points to modest overbought pressure, yet the MACD histogram is positive and the signal line is bullish, hinting at a possible short‑term momentum shift. The stock’s PE of 22.8 is well under the industry average of 31.2, suggesting relative valuation appeal.
Fundamentals show a resilient profit profile with a 15.5% net margin, 19.7% operating margin and an impressive ROE of 76%, albeit on a shrinking revenue base (‑11% YoY). Cash flow remains healthy (operating cash flow $758M, free cash flow $319M) despite a high debt‑to‑equity of 152%, and the modest 1% dividend yield is covered by a low payout ratio of 22%. Analyst sentiment is mixed: the consensus rating is “hold” with a median price target of $545 (+5% upside), while Oppenheimer recently lifted its objective to $645 and reaffirmed an Outperform stance. These dynamics, combined with the “Extreme Greed” market sentiment (fear‑greed index 88.6), position LII as a candidate for investors seeking a blend of value and growth upside.
Fundamentals show a resilient profit profile with a 15.5% net margin, 19.7% operating margin and an impressive ROE of 76%, albeit on a shrinking revenue base (‑11% YoY). Cash flow remains healthy (operating cash flow $758M, free cash flow $319M) despite a high debt‑to‑equity of 152%, and the modest 1% dividend yield is covered by a low payout ratio of 22%. Analyst sentiment is mixed: the consensus rating is “hold” with a median price target of $545 (+5% upside), while Oppenheimer recently lifted its objective to $645 and reaffirmed an Outperform stance. These dynamics, combined with the “Extreme Greed” market sentiment (fear‑greed index 88.6), position LII as a candidate for investors seeking a blend of value and growth upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance level of $524.4
- Decreasing volume and high short‑term volatility
- Bullish MACD histogram suggesting potential reversal
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst upgrades and Oppenheimer price target of $645
- PE ratio well below industry average
- Strong profitability margins and ROE
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend with low payout ratio
- Robust cash flow generation despite high leverage
- Long‑term demand for HVAC and climate‑control solutions
Key Metrics & Analysis
Financial Health
Revenue Growth-11.20%
Profit Margin15.51%
P/E Ratio22.8
ROE75.83%
ROA16.92%
Debt/Equity152.24
P/B Ratio15.6
Op. Cash Flow$757.6M
Free Cash Flow$319.4M
Industry P/E31.2
Technical Analysis
TrendBearish
RSI62.6
Support$434.06
Resistance$524.43
MA 20$473.20
MA 50$510.01
MA 200$531.60
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64
Valuation
Fair Value$74.20
Target Price$546.81
Upside/Downside5.07%
GradeFair
TypeBlend
Dividend Yield1.00%
Risk Assessment
Beta1.17
Volatility45.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.